Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hypochlorous acid (HOCl) is a weak, unstable acid and a powerful oxidizing agent with broad-spectrum antimicrobial activity. It is produced by neutrophils as part of the immune response and is effective against bacteria, viruses, fungi, spores, and biofilms. It disrupts microbial cell membranes, damages DNA and proteins, and inhibits essential enzymes. HOCl is used in wound care, ophthalmology, and dermatology due to its efficacy and safety profile.
Oxidizes and disrupts microbial cell membranes, damages DNA and proteins, and inhibits essential enzymes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hypochlorous Acid (HOCl).